EEF1A2 and lung carcinoma: In humans, eEF1A2 has been shown to have oncogenic properties when inappropriately overexpressed, and has been implicated in ovarian, breast, pancreatic, liver and lung cancer [16], [17], [18], [19], [20], although the mechanism for overexpression remains elusive, and no mutations have been identified in ovarian tumors [21].